Latest News

Vestum (OM:VESTUM) reported another year of rising losses, with the company’s net profit margin remaining stubbornly negative and annual losses compounding at 28.4% over the last five years. Despite the lack of improvement in profitability, earnings are forecast to surge 103.4% annually. Expectations are for Vestum to become profitable in the next three years and revenue is projected to grow at a brisk 6.8% per year. Investors are weighing these growth forecasts against the company’s track...

Wondering whether to buy, sell, or just keep watching Unibail-Rodamco-Westfield? You are not alone. This stock has been catching plenty of attention lately, and for good reason. Over the past year, shares have climbed an impressive 23.6%, and if you look even further, the five-year return sits at a staggering 185.8%. Even in just the past month, the stock has notched a solid 4.0% gain. It is no surprise investors are stopping to take a closer look at what is driving those numbers and whether...

Bilia (OM:BILI A) is forecasting earnings growth of 17.9% per year, outpacing the Swedish market’s 12.3% average. Revenue is similarly expected to grow at 3.7% annually compared to the market’s 3.6%. However, recent profitability tells a more cautious story, as net profit margins are currently 1.6%, down from 2% last year, and earnings have declined by 13.4% per year over the past five years. See our full analysis for Bilia. Next, we will see how these numbers hold up when stacked against the...

If you are staring at Newmont’s ticker and wondering whether now is the moment to buy, sell, or just hold tight, you are not alone. After a whirlwind year, Newmont’s stock has left investors with a lot to process. The share price recently closed at $88.91, which is eye-catching when you look at the wild swings. It is up an impressive 131.7% year-to-date and a solid 84.1% higher than it was twelve months ago. Even the past three years show gains of over 125%. That said, the past week saw a...

If you're holding 3M stock or considering jumping in, you already know it's not just another ticker. In the past year, shares have soared 38.4%, and that's after a robust 13.3% pop over just the last week. Even looking back five years, 3M has delivered more than 56% total return. Clearly, something is propelling the stock, whether it's shifting investor sentiment or reactions to recent headlines. It’s not just market momentum fueling the latest spike. Recent news around 3M’s restructuring...

Comfort Systems USA (FIX) has seen its stock climb nearly 2% in the past month, catching the attention of investors focused on long-term growth. Exploring how recent market activity aligns with the company’s robust financial performance can offer valuable insight. See our latest analysis for Comfort Systems USA. This recent uptick in Comfort Systems USA's share price adds to an impressive run, with a 30-day share price return of 2.6% and a year-to-date return now surpassing 92%. Already, the...

Expro Group Holdings (XPRO) has turned the corner on profitability, reporting average annual earnings growth of 74.8% over the last five years and now expecting earnings to grow at a 12.1% annual rate. Revenue is forecast to increase by 2.1% per year moving forward, trailing the broader US market’s projected growth. While a one-off $34.4 million loss in the most recent 12-month period to September 30, 2025, influenced reported earnings quality, margins are showing clear improvement as the...

Cass Information Systems (CASS) posted a net profit margin of 9.8% for the latest period, down from 13% in the previous year. The company’s revenue is projected to grow at 5.7% annually, which trails the broader US market growth rate of 10%. Over the last five years, earnings have declined at an average pace of 2.9% per year, and the current price-to-earnings ratio stands at 24.2x, exceeding both its peer average and industry benchmarks. The story for investors centers on slower growth and...

First Internet Bancorp (INBK) is currently unprofitable, with losses deepening at a rate of 28% per year over the past five years. However, analysts project a sharp turnaround, forecasting earnings growth of 186.19% per year and a return to profitability within the next three years. Revenue is expected to surge at 62.9% per year, outpacing the broader US market’s 10% growth. Investors appear focused on these powerful growth catalysts, as well as the company’s attractive Price-To-Book Ratio of...

Earlier in October 2025, One Inc. announced a collaboration with Copart, Inc. to integrate ClaimsPay with Copart's Title Express and Loan Payoff system, aiming to digitize and accelerate lienholder payments for total loss vehicle claims across the insurance and auto finance ecosystem. This initiative replaces traditional, paper-based processes with a digital network, helping insurers, banks, and vehicle owners achieve faster settlements and improved efficiency in claims and title...

Bokusgruppen (OM:BOKUS) reported earnings growth of 10.9% over the past year, slipping below its five-year annual average of 17.1%. Net profit margins held steady at 2.4%, while revenue is projected to grow by 3% annually, slightly behind the broader Swedish market’s anticipated 3.6% per year. Investors are likely to weigh Bokusgruppen’s solid earnings track record and attractive price-to-earnings ratio of 25.5x, well beneath the peer average, against concerns about dividend sustainability...

Thinking about what to do with Figma stock right now? You are not alone. After a high-flying debut and a stint as a darling of collaborative design, Figma’s share price has come back to earth lately. Over just the past week, the stock dropped 7.7%, and it is down 8.2% for the month. If you had bought at the start of the year, that experience would have felt even bumpier, with shares sliding a steep 53.8% year-to-date. For new and long-term investors alike, these moves may stir up questions,...

West Fraser Timber (TSX:WFG) remains in the red, with losses accelerating at a rate of 48.5% per year over the past five years and net profit margins still negative. Despite the ongoing unprofitability, revenue is forecast to grow 6.3% annually, outpacing the Canadian market’s 4.9% average. Earnings are projected to jump 58.75% per year. The company is expected to become profitable within three years. This aggressive growth outlook is a key focus for investors who must weigh strong forecasts...

TD SYNNEX (SNX) just reported its revenues grew 7% over the past year, coming in ahead of forecasts and setting new records for both billings and earnings. The company also unveiled a new global FinOps Practice powered by IBM Cloudability, signaling a strategic push in cloud financial management. See our latest analysis for TD SYNNEX. TD SYNNEX's recent momentum has caught the market’s attention, helped along by positive news: leadership changes, new distribution partnerships, and the...

If you’ve been thinking about what to do with your shares of Praxis Precision Medicines or are simply curious about the meteoric moves you’ve seen on the chart, you’re in the right place. The stock has delivered a jaw-dropping 266.3% gain over the past month and a remarkable 123.9% increase year-to-date, numbers that catch the eye of even the most seasoned investors. Over the last year, Praxis has soared 152.5%, and the three-year return clocks in at an astonishing 514.9%. While these rapid...

Afya (NasdaqGS:AFYA) stock has delivered mixed returns across different timeframes, with shares slipping 7% over the past month but showing a 4% gain in the past 3 months. The company reported annual revenue growth of 8% and net income growth of 18%. See our latest analysis for Afya. While Afya’s share price recently dipped, long-term momentum has been mixed, with a 1-year total shareholder return of -10.2% and a modest 3-year total return of nearly 7%. These shifts hint at evolving sentiment...

Atai Life Sciences recently closed a public equity offering, raising approximately US$149.5 million to advance clinical trials for mental health treatments, following the FDA's Breakthrough Therapy designation for its BPL-003 nasal spray targeting treatment-resistant depression. This combination of significant fundraising and regulatory momentum positions Atai to accelerate late-stage development and potentially address large unmet needs in mental health care. We'll examine how the FDA's...

Parke Bancorp (PKBK) posted a 42.1% year-over-year surge in earnings, easily outpacing its five-year average annual decline of 4.9%. Net profit margins widened to 46.3% from last year’s 33.7%, highlighting better profitability, while the company now trades at an 8.3x Price-to-Earnings ratio, which is below both peers and the broader US banks industry. With improved profit growth, a higher margin, and valuation multiples below industry benchmarks, investors may see fresh reasons for optimism,...

Kitron (OB:KIT) saw its net profit margin slip to 4.5% from 5.4% last year, reflecting a dip in profitability. While earnings declined year over year, forecasts point to a sharp rebound with earnings set to climb 18.26% per year and revenue projected to gain 14% annually. This is well above the 3.9% pace expected for the broader Norwegian market. Despite elevated valuation multiples relative to industry peers, strong growth forecasts on both top and bottom lines remain a key draw for...

NVE Corporation (NVEC) posted a net profit margin of 55.8%, down from 58.9% in the previous period, reflecting some margin pressure. While the company averaged 5% annual earnings growth over the past five years, the most recent year saw earnings retreat into negative territory, marking a notable break from its established trend. The shares trade at a Price-To-Earnings Ratio of 25.2x, undercutting both the peer average of 58.1x and the broader US semiconductor sector's 36.1x. However, the...

flatexDEGIRO (XTRA:FTK) booked revenue growth of 8.3% per year, beating the German market’s expected 6% pace. Earnings are projected to climb 16.2% annually, just a touch below the market average of 16.6%. The profit margin held steady at 26.1% with a one-year earnings growth of 17.4% compared to a five-year average of 20.8% per year. Investors see a strong balance of rewards here as high-quality earnings, value against peers and discounted cash flow models, and an absence of flagged risks...

PG&E (PCG) reported modest revenue growth of 3.1% per year and an annual earnings growth rate of 9.73%, both of which trail the broader US market averages. Net profit margins came in at 9.6%, down from 10.2% last year, as a significant one-off loss of $609.0 million weighed on results. Despite these mixed figures, investors may focus on PG&E’s lower price-to-earnings ratios compared to peers and the potential for positive sentiment if growth trends continue. At the same time, concerns remain...

In October 2025, American Resources Corporation completed two significant private placements, raising approximately US$40 million and an additional US$33 million from institutional investors to support its rare earth element extraction and processing activities. The company’s portfolio firm, ReElement Technologies, is expanding production and recently signed a rare earth offtake agreement with POSCO International America Corp, signaling heightened momentum in American Resources’ rare earth...

Thinking about what to do with Bank of New York Mellon stock right now? You’re not alone. With the share price chart looking like a mountain range, plenty of investors are trying to read the latest signals. The stock has cooled off just a touch over the past month, dipping -1.8%, but zoom out and you’ll notice some impressive momentum. Year-to-date returns are up a stunning 37.8%, and the stock has climbed 41.8% over the past year. The real eye-opener is that in five years, Bank of New York...